The Effect of Covalently Immobilized FGF-2 on Biphasic Calcium Phosphate Bone Substitute on Enhanced Biological Compatibility and Activity

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Designation</td><td align="left">Explanation</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Con (Control)</td><td align="left">Uncoated biphasic calcium phosphate (BCP)</td></tr><tr><td align="center" colspan="2"><hr/></td></tr><tr><td align="left">20D</td><td align="left">Cell cultured on BCP dosed with 20 ng FGF-2 every 2 days</td></tr><tr><td align="center" colspan="2"><hr/></td></tr><tr><td align="left">10C, 50C, 100C, 200C, and 400C</td><td align="left">10, 50, 100, 200, and 400 ng FGF-2 covalently coated BCP</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Detailed information of experimental specimens used in this study.

BioMed Research International

tab2

Table 2

Table 2: The Effect of Covalently Immobilized FGF-2 on Biphasic Calcium Phosphate Bone Substitute on Enhanced Biological Compatibility and Activity 